novocure20limited  (NVCR) - nasdaqgs

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2021
(Fiscal Year)
2020
(Fiscal Year)
2019
(Fiscal Year)
March      
   Revenue $134,695(t) $101,828(t) $73,309(t)
   EPS -0.04 (3/31/2021) 0.04 (3/31/2020) -0.13 (3/31/2019)
   Dividends N/A N/A N/A
June      
   Revenue   $115,925(t) $86,713(t)
   EPS   0.01 (6/30/2020) -0.01 (6/30/2019)
   Dividends   N/A N/A
September      
   Revenue   $132,660(t) $92,062(t)
   EPS   0.09 (9/30/2020) 0.02 (9/30/2019)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $143,953(t) $99,234(t)
   EPS   0.04 (12/31/2020) 0.05 (12/31/2019)
   Dividends   N/A N/A
Totals      
   Revenue $134,695(t) $494,366(t) $351,318(t)
   EPS -0.04 0.18 -0.07
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.